台股 » 個股 » 智擎 » 籌碼相關 » 主力籌碼集中度

智擎

(4162)
可現股當沖
  • 股價
    100.5
  • 漲跌
    ▼3.0
  • 漲幅
    -2.90%
  • 成交量
    1,644
  • 產業
    上櫃 生技醫療類股
  • 309人加入追蹤

    立即追蹤

  • 本地時間:14:30(已收盤)

     
智擎 (4162)籌碼相關-主力籌碼集中度
籌碼集中度

市場上除了三大法人之外,有些主力大戶在買賣股票的資訊並不會被揭露,而這些主力通常卻又是影響股票價格變動的主因。當主力反覆買進/賣出某支股票,則該股籌碼集中度就會變高/變低,而通常籌碼集中度越高,越有可能出現大行情。我們將主力在券商進出的數據做出統計,給您參考!

智擎 (4162)主力籌碼與董監持股比重走勢圖

Created with Highstock 1.3.7嗨投資 histock.tw籌碼集中度外資籌碼大戶籌碼董監持股2020/07/012021/01/012021/07/012022/01/012022/07/012023/01/012023/07/012024/01/012024/07/012025/01/010%20%40%60%
Created with Highstock 1.3.7嗨投資 histock.tw籌碼集中度收盤價2020/07/012021/01/012021/07/012022/01/012022/07/012023/01/012023/07/012024/01/012024/07/012025/01/0140%45%50%55%60%50元100元150元0元
Created with Highstock 1.3.7嗨投資 histock.tw外資籌碼收盤價2020/07/012021/01/012021/07/012022/01/012022/07/012023/01/012023/07/012024/01/012024/07/012025/01/012.5%5%7.5%10%12.5%50元100元150元0元
Created with Highstock 1.3.7嗨投資 histock.tw大戶籌碼收盤價2020/07/012021/01/012021/07/012022/01/012022/07/012023/01/012023/07/012024/01/012024/07/012025/01/0135%40%45%50%50元100元150元0元

智擎 (4162)主力籌碼集中度 歷史資料

日期籌碼
集中度
外資
籌碼
大戶
籌碼
董監
持股
2025/03/2849.87%9.30%40.57%33.26%
2025/03/2150.64%9.28%41.36%33.26%
2025/03/1449.83%9.02%40.81%33.26%
2025/03/0749.69%8.14%41.55%33.26%
2025/02/2750.64%8.44%42.20%33.26%
2025/02/2150.92%8.25%42.67%33.26%
2025/02/1451.10%8.56%42.54%33.26%
2025/02/0851.99%9.43%42.56%33.26%
2025/01/2449.37%7.23%42.14%33.26%
2025/01/1749.35%7.37%41.98%33.26%
2025/01/1049.57%7.52%42.05%33.26%
2025/01/0348.58%6.66%41.92%33.26%
2024/12/2748.84%6.62%42.22%33.26%
2024/12/2048.64%6.60%42.04%33.26%
2024/12/1348.72%6.59%42.13%33.26%
2024/12/0649.03%6.37%42.66%33.26%
2024/11/2949.51%7.28%42.23%33.26%
2024/11/2249.29%7.39%41.90%33.26%
2024/11/1548.67%7.64%41.03%33.26%
2024/11/0848.40%7.22%41.18%33.26%
2024/11/0146.87%5.78%41.09%33.26%
2024/10/2546.29%5.80%40.49%33.26%
2024/10/1845.86%5.87%39.99%33.26%
2024/10/1145.86%5.95%39.91%33.26%
2024/10/0445.71%6.01%39.70%33.26%
2024/09/2745.27%5.94%39.33%33.26%
2024/09/2045.36%5.93%39.43%33.26%
2024/09/1345.30%5.70%39.60%33.26%
2024/09/0645.22%5.63%39.59%33.26%
2024/08/3045.22%5.69%39.53%33.26%
2024/08/2345.25%5.54%39.71%33.26%
2024/08/1645.19%5.50%39.69%33.26%
2024/08/0945.54%5.51%40.03%33.26%
2024/08/0244.88%5.23%39.65%33.26%
2024/07/2645.43%5.73%39.70%33.26%
2024/07/1946.02%5.28%40.74%33.26%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-26天前
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章